Kinnate Biopharma Inc (KNTE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -112,649 | -116,271 | -89,763 | -35,761 | -11,969 |
| Depreciation Amortization | -3,608 | 1,286 | 2,000 | 88 | N/A |
| Accounts receivable | N/A | N/A | N/A | 973 | -49 |
| Other Working Capital | -3,704 | 6,369 | 1,624 | 3,014 | 1,404 |
| Other Operating Activity | 19,918 | 19,582 | 15,074 | 1,505 | 88 |
| Operating Cash Flow | $-100,043 | $-89,034 | $-71,065 | $-30,181 | $-10,526 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -154,719 | -176,528 | -247,142 | -31,412 | N/A |
| PPE Investments | N/A | -2,719 | -769 | -297 | N/A |
| Sale Of Investment | 264,588 | 172,417 | 67,337 | N/A | N/A |
| Investing Cash Flow | $109,869 | $-6,830 | $-180,574 | $-31,709 | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 1,325 | 1,566 | 1,619 | 253,209 | 1 |
| Other Financing Activity | -9,133 | -406 | 34,618 | 97,690 | 79,979 |
| Financing Cash Flow | $-7,808 | $1,160 | $36,237 | $350,899 | $79,980 |
| Exchange Rate Effect | -6 | 1 | 0 | N/A | N/A |
| Beginning Cash Position | 55,357 | 150,060 | 365,462 | 76,453 | 6,999 |
| End Cash Position | 57,369 | 55,357 | 150,060 | 365,462 | 76,453 |
| Net Cash Flow | $2,012 | $-94,703 | $-215,402 | $289,009 | $69,454 |
| Free Cash Flow | |||||
| Operating Cash Flow | -100,043 | -89,034 | -71,065 | -30,181 | -10,526 |
| Capital Expenditure | 0 | -2,719 | -769 | -297 | N/A |
| Free Cash Flow | -100,043 | -91,753 | -71,834 | -30,478 | -10,526 |